Endocrinology, Diabetes & Metabolism Doctors in Michigan City, IN Accepting Medicare

3 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 3

David Baldwin Jr., M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1225 E Coolspring Ave Ste 2c, Michigan City, IN 46360 Phone: 219-877-1298    Fax: 219-877-1016

Dr. Vrinda Agrawal, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 301 W Homer St, Michigan City, IN 46360 Phone: 219-877-1298    Fax: 219-877-1016

Ludovicus Dekeyser, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1501 Wabash, Suite #400b, Michigan City, IN 46360 Phone: 219-877-1298    Fax: 219-877-1016

News Archive

Eight students to continue medical education in St. Luke's Graduate Medical Education programs

Friday, March 20 was the end of a long process for medical students, said Dr. Joel Rosenfeld, MD, M.Ed, FACS, Chief Academic Officer, St. Luke's University Health Network. "National Match Day is truly a milestone for every medical student across the country. This is the day when medical residency programs match with their highest-ranked medical students, and medical students learn where they will continue their medical training as residents."

Cyplasin selects Aurobindo Pharma to supply API component for Ribavirin drug

Cyplasin Biomedical is a product-oriented, specialty pharmaceutical company focused on developing products for the multi-billion dollar hepatitis C virus (HCV) market. The Company is pleased to announce that it has selected Aurobindo Pharma located in Hyderabad , India to supply the active pharmaceutical ingredient (API) component for its Ribavirin drug product called C-Virin.

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

New data from the randomized, placebo-controlled TWILIGHT trial found that compared to ticagrelor plus aspirin, ticagrelor monotherapy reduces bleeding events without increasing the risk of death, myocardial infarction, or stroke in high-risk patients who have undergone successful percutaneous coronary intervention and completed three months of dual antiplatelet therapy.

Inter Press Service features interview with incoming FAO director general

Inter Press Service features excerpts from an interview with Jose Graziano da Silva, former Brazilian minister of food security, "who takes over as the new director general of the U.N. Food and Agriculture Organization (FAO) on January 1."

Read more Medical News

› Verified 6 days ago